Influenza pandemics, immune cross-reactivity, and pandemic control strategies

Journal of Infectious Diseases

Volumn 198, Issue 2, 2008, Pages 294-295

  Gioia, Cristiana ^a   Agrati, Chiara ^a   Castilletti, Concetta ^a   Capobianchi, Maria R ^a   Martini, Federico ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY PRODUCTION; AUTUMN; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; LETTER; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; SUMMER; VIRUS TITRATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; BIRDS; CROSS REACTIONS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 47649122280     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/589302     Document Type: Letter

References (6)

1. Andreasen V, Viboud C, Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008; 197:270-8.
2. Gioia C, Castilletti C, Tempestilli M, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerging Infectious Diseases 2008; 14:121-8.
3. Lu X, Edwards LE, Desheva JA, et al. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenzaA(H5N1) viruses. Vaccine 2006; 24:6588-93.
4. Ichinohe T, Tamura S, Kawaguchi A, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007; 196:1313-20.
5. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007; 4:e59.
6. Boni MF, Gog JR, Andreasen V, Christiansen FB. Influenza drift and epidemic size: the race between generating and escaping immunity. Theor Popul Biol 2004; 65:179-91.